Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Auditor change
Appointed director
|
|
Eidos Therapeutics, Inc. (EIDX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/13/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 01/13/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 01/12/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 01/12/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 01/07/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 01/04/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 12/29/2020 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 12/28/2020 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 11/02/2020 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 10/06/2020 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 10/06/2020 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 10/05/2020 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 10/05/2020 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 10/05/2020 |
425
| Form 425 - Prospectuses and communications, business combinations: |
|
|